30
41
Growth Score
-5 pts
Heat Score
-29 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
358388
Scantox is a pre-clinical contract research organization that offers toxicology, pharmacology, and endotoxin testing services.
- Matt Tate: Chief Business Development OfficerPast Role: Gentronix, Chief Executive Officer
- Johanna Lindvall: Operational ManagerPast Role: Q&Q Labs AB, Co-Founder
About the Company
Scantox is a contract research organization that specializing in pharmacology and regulatory toxicology services. Their preclinical contract research services enable clients to progress their drug or device development. They offer various contract research services such as safety pharmacology, exploratory, and endotoxin testing.
